Magnetic Resonance Imaging
Volume 28, Issue 9 , Pages 1251-1257 , November 2010

Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study

  • Mona A. Mohamed

      Affiliations

    • Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD 21287, USA
    • F.M. Kirby Center for Functional Brain Imaging, the Kennedy Krieger Institute, Baltimore, MD 21287, USA
    • ,
  • Peter B. Barker

      Affiliations

    • Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD 21287, USA
    • F.M. Kirby Center for Functional Brain Imaging, the Kennedy Krieger Institute, Baltimore, MD 21287, USA
    • ,
  • Richard L. Skolasky

      Affiliations

    • Department of Orthopaedic Surgery, Johns Hopkins University, Baltimore, MD 21287, USA
    • Affiliated with the Orthopedic Surgery Department of the Johns Hopkins University School of Medicine and conducted the statistical analysis.
    • ,
  • Ola A. Selnes

      Affiliations

    • Department of Neurology, Johns Hopkins University School of Medicine Baltimore, MD 21287, USA
    • ,
  • Richard T. Moxley

      Affiliations

    • Department of Neurology, Johns Hopkins University School of Medicine Baltimore, MD 21287, USA
    • ,
  • Martin G. Pomper

      Affiliations

    • Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD 21287, USA
    • ,
  • Ned C. Sacktor

      Affiliations

    • Department of Neurology, Johns Hopkins University School of Medicine Baltimore, MD 21287, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 410 550 0978; fax: +1 410 550 0539.

Received 22 January 2010 ,Accepted 11 June 2010.

References 

  1. Fine SM, Angel RA, Perry SW, Epstein LG, Rothstein JD, Dewhurst S, et al. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem. 1996;271:15303–15306
  2. Everall IP, Luthert PJ, Lantos PL. Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry. 1993;56:481–486
  3. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986;19:525–535
  4. Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest. 1992;66:285–291
  5. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, et al. Neocortical damage during HIV infection. Ann Neurol. 1991;29:651–657
  6. Power C, McArthur JC, Nath A, Wehrly K, Mayne M, Nishio J, et al. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol. 1998;72:9045–9053
  7. Van Zijl PC, Barker PB. Magnetic resonance spectroscopy and spectroscopic imaging for the study of brain metabolism. Ann N Y Acad Sci. 1997;820:75–96
  8. Chong WK, Sweeney B, Wilkinson ID, Paley M, Hall-Craggs MA, Kendall BE, et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology. 1993;188:119–124
  9. Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I, et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology. 1999;53:782–789
  10. Menon DK, Ainsworth JG, Cox IJ, Coker RC, Sargentoni J, Coutts GA, et al. Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr. 1992;16:538–542
  11. Meyerhoff DJ, MacKay S, Poole N, Dillon WP, Weiner MW, Fein G. N-Acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals. Magn Reson Imaging. 1994;12:653–659
  12. Barker PB, Lee RR, McArthur JC. AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology. 1995;195:58–64
  13. Laubenberger J, Häussinger D, Bayer S, Thielemann S, Schneider B, Mundinger A, et al. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology. 1996;199:805–810
  14. Navia BA, Rostasy K. The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies. Neurotox Res. 2005;8:3–24
  15. Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, Schifitto G, et al. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J Neuropsychiatry Clin Neurosci. 2007;19:283–292
  16. Jansen JF, Backes WH, Nicolay K, Kooi ME. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology. 2006;240(2):318–332
  17. Natt O, Bezkorovaynyy V, Michaelis T, Frahm J. Use of phased array coils for a determination of absolute metabolite concentrations. Magn Reson Med. 2005;53:3–8
  18. Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med. 2001;45:765–769
  19. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8:136–142
  20. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30:672–679
  21. Sacktor N, Skolasky RL, Ernst T, Mao X, Selnes O, Pomper MG, et al. A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging. 2005;21(4):325–333
  22. Strange K, Emma F, Parades A, Morrison R. Osmoregulation changes in myo-inositol content and Na+/myo-inositol cotransport in rat cortical astrocytes. Glia. 1994;12(1):35–43
  23. Barker PB, Szopinski K, Horska A. Metabolic heterogeneity at the level of the anterior and posterior commissures. Magn Reson Med. 2000;43:348–354
  24. Wang Z, Pekarskaya O, Bencheikh M, Chao W, Gelbard HA, Ghorpade A, et al. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology. 2003;312:60–73
  25. Sailasuta N, Shriner K, Ross B. Evidence of reduced glutamate in the frontal lobe of HIV-seropositive patients. NMR Biomed. 2009;22:326–331
  26. Chang L, Ernst T, St Hillaire C, Conant K. Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients. Antivir Ther. 2004;9(3):431–440
  27. Petroff OA, Errante LD, Rothman DL, Kim JH, Spencer DD. Neuronal and glial metabolite content of the epileptogenic human hippocampus. Ann Neurol. 2002;52:635–642
  28. Sardar AM, Hutson PH, Reynolds GP. Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS. Neuroreport. 1999;10:3513–3515
  29. Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, et al. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology. 2001;57:671–675
  30. Espey MG, Ellis RJ, Heaton RK, Basile AS. Relevance of glutamate levels in the CSF of patients with HIV-1-associated dementia complex. Neurology. 1999;53:1144–1145
  31. Vesce S, Bezzi P, Rossi D, Meldolesi J, Volterra A. HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett. 1997;411:107–109

☆ Disclosure: The authors report no conflict of interest.

PII: S0730-725X(10)00164-5

doi: 10.1016/j.mri.2010.06.007

Magnetic Resonance Imaging
Volume 28, Issue 9 , Pages 1251-1257 , November 2010

Article Tools

* Image Usage & Resolution